Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
TG Therapeutics, Inc. (TGTX) had Weighted-Average Shares Outstanding (Diluted) of 160.34M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$329.00M |
|
$23.38M |
|
$38.49M |
|
$290.52M |
|
$287.07M |
|
$41.93M |
|
$-16.34M |
|
$25.59M |
|
$25.59M |
|
$23.38M |
|
$23.38M |
|
$23.38M |
|
$23.38M |
|
$41.93M |
|
$37.22M |
|
145.32M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
160.34M |
$0.16 |
|
$0.15 |
|
| Balance Sheet Financials | |
$566.36M |
|
-- |
|
$11.33M |
|
$577.69M |
|
$90.68M |
|
$244.43M |
|
$264.65M |
|
$355.33M |
|
$222.36M |
|
$222.36M |
|
$222.36M |
|
155.84M |
|
| Cash Flow Statement Financials | |
$-40.52M |
|
$-1.04M |
|
$128.53M |
|
$94.22M |
|
$181.19M |
|
$86.97M |
|
$42.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.25 |
|
-- |
|
-- |
|
0.52 |
|
1.10 |
|
88.30% |
|
12.74% |
|
12.74% |
|
11.31% |
|
7.78% |
|
7.11% |
|
$-40.56M |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
0.35 |
|
2.55 |
|
143.32 |
|
10.52% |
|
10.52% |
|
4.05% |
|
5.01% |
|
$1.43 |
|
$-0.25 |
|
$-0.25 |
|